Atherotech Develops Tests To Determine Blood Clotting Risk

bbj-300Atherotech Diagnostics Lab is working to thin out blood clotting problems for people who suffer from thrombophilia.

The Birmingham-based clinical reference lab announced Thursday that its new tests will measure sensitivity to Warfarin and Plavix – two widely prescribed blood thinning drugs – and perform the thrombophilia risk test. The thrombophilia test looks for specific gene mutations in patients who have the blood clotting disorder.

The Warfarin and Plavix tests will see how patients metabolize those drugs. An Atherotech news release said those tests can help doctors determine the right dosage or consider a medication change to help prevent clots that can lead to heart attack or stroke.

The full article is located at Birmingham Business Journal

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s